June 19, 2024

Blood Culture Test Market Size To Surpass USD 16.31 Bn By 2032

The global blood culture test market size was valued at  USD 6.03 billion in 2023 and is projected to reach around USD 16.31 billion by 2032, at a CAGR of 11.70% during the forecast period from 2023 to 2032.

Blood Culture Test Market Size 2023 To 2032

Key Takeaways

  • North America region contributed more than 40% of revenue share in 2022.
  • The Asia-Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
  • By product, the consumables segment has held the largest market share of 59% in 2022.
  • By product, the instruments segment is anticipated to grow at a remarkable CAGR of 12.5% between 2023 and 2032.
  • By technique, the conventional segment generated over 62% of revenue share in 2022.
  • By technique, the automated segment is expected to expand at the fastest CAGR over the projected period.
  • By application, the bacterial infections segment generated over 70% of revenue share in 2022.
  • By application, the mycobacterial infections segment is expected to expand at the fastest CAGR over the projected period.
  • By technology, the culture-based segment generated over 67% of revenue share in 2022.
  • By technology, the proteomic technology segment is expected to expand at the fastest CAGR over the projected period.

The blood culture test market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market

The study offers intricate dynamics about different aspects of the global blood culture test market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global blood culture test market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/3615

Blood Culture Test Market Scope

Report CoverageDetails
Growth Rate from 2023 to 2032CAGR of 11.70%
Market Size in 2023USD 6.03 Billion
Market Size by 2032USD 16.31 Billion
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Product, By Technique, By Application, By Technology
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read Also: Business-to-Business E-commerce Market Size To Worth USD 44.88 Trn By 2032

This study covers an elaborate segmentation of the global blood culture test market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global blood culture test market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.

Blood Culture Test Market Players

  • Becton, Dickinson and Company (BD)
  • bioMérieux
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Beckman Coulter (a subsidiary of Danaher Corporation)
  • Bruker Corporation
  • Cepheid (a Danaher company)
  • Luminex Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Accelerate Diagnostics
  • Alere Inc. (now part of Abbott)
  • COPAN Diagnostics, Inc.
  • Nanosphere (acquired by Luminex Corporation)
  • T2 Biosystems

Segments Covered in the Report

By Product

  • Consumables
  • Software & Services
  • Instruments

By Technique

  • Conventional
  • Automated

By Application

  • Bacterial Infections
  • Fungal Infections
  • Mycobacterial Infections

By Technology

  • Culture-based Technology
  • Molecular Technology
  • Proteomic Technology

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

The research methodology acquire by analysts for assemble the global blood culture test market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global blood culture test market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Culture Test Market 

5.1. COVID-19 Landscape: Blood Culture Test Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Culture Test Market, By Product

8.1. Blood Culture Test Market, by Product, 2023-2032

8.1.1. Consumables

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Software & Services

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Instruments

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Blood Culture Test Market, By Technique

9.1. Blood Culture Test Market, by Technique, 2023-2032

9.1.1. Conventional

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Automated

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Blood Culture Test Market, By Application 

10.1. Blood Culture Test Market, by Application, 2023-2032

10.1.1. Bacterial Infections

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Fungal Infections

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Mycobacterial Infections

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Blood Culture Test Market, By Technology 

11.1. Blood Culture Test Market, by Technology, 2023-2032

11.1.1. Culture-based Technology

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Molecular Technology

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Proteomic Technology

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Blood Culture Test Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Technique (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Technique (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Technique (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Technique (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Technique (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Technique (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Technique (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Technique (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Technique (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Technique (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Technique (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Technique (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Technique (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Technique (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Technique (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Technique (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Technique (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Technique (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Technology (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Technique (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Technique (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Technique (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Technology (2020-2032)

Chapter 13. Company Profiles

13.1. Becton, Dickinson and Company (BD)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. bioMérieux

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Roche Diagnostics

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Beckman Coulter (a subsidiary of Danaher Corporation)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bruker Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Cepheid (a Danaher company)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Luminex Corporation

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Bio-Rad Laboratories

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Siemens Healthineers

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com